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Available online 8 September 2016Thiswork pertains to GEO submission GSE36672, in vivo and in vitro genomewide binding (ChIP-Seq) of Bapx1/
Nkx3.2 and Sox9 proteins. We have previously shown that data from a genome wide binding assay combined
with transcriptional proﬁling is an insightful means to divulge the mechanisms directing cell type speciﬁcation
and the generation of tissues and subsequent organs [1]. Our earlier work identiﬁed the role of the DNA-binding
homeodomain containing protein Bapx1/Nkx3.2 in midgestation murine embryos. Microarray analysis of EGFP-
tagged cells (both wildtype and null) was integrated using ChIP-Seq analysis of Bapx1/Nkx3.2 and Sox9 DNA-
binding proteins in living tissue.
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2.1. Experimental approach
The information presented here has been previously described in
Chatterjee et al. (2014) “In vivo genome-wide analysis of multiple tis-
sues identiﬁes gene regulatory networks, novel functions and down-
stream regulatory genes for Bapx1 and its co-regulation with Sox9 in
the mammalian vertebral column.” [1]. An overview of the experimen-
tal approach is shown in Fig. 1. The Bapx1/Nkx3.2 protein was tagged in
vivowith the S-peptide epitope to give speciﬁcity to the isolation of the
Bapx1/Nkx3.2 S-peptide fusion protein for immunoprecipitation. In a
similar fashion, the Bapx1/Nkx3.2 cDNA was engineered so as to have
an in-frame fusion with the V5 epitope tag that has a well-established
high degree of speciﬁcity for the corresponding anti-V5 antibody and
is commonly used in in vitro cell culture systems following the overex-
pression of the V5-tagged protein. In this case the V5-Bapx1/Nkx3.2 fu-
sion protein was employed in electrophoretic mobility shift assays
(EMSA). The vertebral columns of mid-gestation (E12.5)mouse embry-
os carrying the Bapx1/Nkx3.2 S-peptide allele were carefully dissected
away from surrounding embryonic tissues, disaggregated into micro
pieces and chromatin immunoprecipitation was performed to identify
the DNA sequences bound by Bapx1/Nkx3.2 protein in the native in
vivomurine vertebral column.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Overview of the strategy for performing ChIP-seq on genetically modiﬁed Bapx1/Nkx3.2 by the addition of an S-protein epitope tag to the N-terminus of the endogenous Bapx1/
Nkx3.2 protein-encoding sequence. Once correctly targeted ES clones are identiﬁed they are used to generate germline transmitting chimeras and subsequent stable lines of mice
expressing the S-protein- Bapx1/Nkx3.2 fusion protein. S-protein tagged Bapx1/Nkx3.2 expressing embryos are isolated mid-gestation and the vertebral columns are removed. The
isolated cells are cross-linked with ﬁxitive, DNA is isolated and sheared and anti-S-protein antibody is employed for immunoprecipitation. The isolated DNA which is enriched for
Bapx1/Nkx3.2 genomic binding sites is sequenced and mapped to the lastest build of the mouse genome.
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The “Quick and Easy” BAC modiﬁcation kit (Gene Bridges) was used
to generate Bapx1/Nkx3.2 gene targeting constructs as we have previ-
ously described [2, 3] using C57BL/6J strain murine BAC clones contain-
ing the Bapx1/Nkx3.2 gene obtained from the BACPAC Resources Centre
at Children’s Hospital Oakland Research Institute (CHORI). Fragments of
each modiﬁed region ﬂanked by short and long homology arms with a
total average length of N10 kb were subcloned into a minimal vector
with the Gene Bridges BAC Subcloning kit. The resulting plasmids
were linearized and electroporated into ES cells previously we de-
scribed [2,3]. Normal karyotype ES clones positive by DNA blotting
with probes external to the gene targeting constructs were used to gen-
erate germline transmitting chimeras as we have previously described
[4]. The resulting highly chimeric mice were crossed to C57BL/6J mice
and stable mouse lines were established expressing the S-peptide
tagged Bapx1/Nkx3.2 protein. The FRT-ﬂanked neomycin G418 antibiotic
selection cassette in the targeted Bapx1/Nkx3.2 allele was deleted
by crossing to FLPe–deleter mice (129S4/SvJaeSor-Gt(ROSA)26Sor
tm1(FLP1)Dym/J (Stock #3946) from Jackson Laboratories) [5,6].
Genotyping ofBapx1/Nkx3.2 lineswas performedbyPCR essentially as de-
scribed [7]. RNA in situ analysis was performed as previously described
[8] on the resulting modiﬁed allele carrying embryos to verify that there
were no detectable changes in expression of the gene-targeted locus.
For analysis of the vertebral column the E12.5 embryos were sectioned
through the sagittal plane [9].
2.3. Chromatin immunoprecipitation and DNA-binding motif analysis
Wildtype or Baxp1/Nkx3.2 gene-targeted mouse lines were mated
and noon of the plug date was designated as E0.5. At E12.5 embryos
were isolated and the vertebral columns (tagged with S-peptide forBaxp1/Nkx3.2 or wildtype mouse embryos for Sox9) were carefully
dissected away from other organs and pooled. An overview of the
experimental approach is shown in Fig. 1. Chromatin (~2 mg) was
used for chromatin immunoprecipitation as previously described for
Bapx1/Nkx3.2 and Sox9 [10]. With 15 ng of puriﬁed ChIP DNA from
each sample, the sequencing library was generated according to the
manufacturer’s instructions (Illumina) [1,11]. Antibodies used for
Bapx1/Nkx3.2 and Sox were anti S-Peptide antibody (Bethyl laborato-
ries, A190-134A) and anti-Sox9 antibody (R&D Systems, AF3075)
respectively. The Illumina Genome Analyzer Pipeline was used to map
reads that had passed signal ﬁltering to the murine mm9 genome. The
Illumina Genome Analyzer II/Iix produced sequence reads. The peak
calling algorithmMACS was used to match unique reads with 2 or less
mismatches, with default settings as previously described [12]. ChIP-
Seq peak annotation is as previously described [1,11]. All data was de-
posited in Gene Expression Omnibus (GEO) under accession number
GSE36672. 2815 Bapx1/Nkx3.2 peaks were detected at the TSS (540).
Many binding sites, however, were located far from a TSS; some located
at over 25 kb distally in the intergenic (1052) and less located over
25 kb in the intragenic regions (722). Many peaks were identiﬁed for
Sox9 (3722). DNA-binding motif analysis used the top several hundred
peaks and the masked repeat genome sequence spanned on either side
from the summit of these peaks by 50 bp.MACS determined peakswere
ranked as described [1]. The DNA binding motif for Sox9 was deter-
mined mostly by in vitro studies [13]. We identiﬁed the Bapx1/Nkx3.2
binding motif [14] enriched in about 40% of the Bapx1/Nkx3.2 binding
sites [1,11]. Gene enrichment test for regions bound by Sox9 and
Bapx1,we submitted the analyzed ChIP-Seqdata as bed format to Geno-
mic Regions Enrichment of Annotations Tool (GREAT) [15] version 1.8
with the following parameters, species assembly-mm9 and Association
rule-Single nearest gene: 100,000 bp maximum extension, curated reg-
ulatory domains included.
53S. Chatterjee et al. / Genomics Data 10 (2016) 51–53References
[1] S. Chatterjee, V. Sivakamasundari, S.P. Yap, P. Kraus, V. Kumar, X. Xing, S.L. Lim, J.
Sng, S. Prabhakar, T. Lufkin, In vivo genome-wide analysis of multiple tissues iden-
tiﬁes gene regulatory networks, novel functions and downstream regulatory genes
for Bapx1 and its co-regulation with Sox9 in themammalian vertebral column. BMC
Genomics 15 (2014) 1072, http://dx.doi.org/10.1186/1471-2164-15-1072.
[2] H.Y. Chan, V. Sivakamasundari, X. Xing, P. Kraus, S.P. Yap, P. Ng, S.L. Lim, T. Lufkin,
Comparison of IRES and F2A-based locus-speciﬁc multicistronic expression in stable
mouse lines. PLoS One 6 (2011), e28885, http://dx.doi.org/10.1371/journal.pone.
0028885.
[3] W. Wang, P. Lo, M. Frasch, T. Lufkin, Hmx: an evolutionary conserved homeobox
gene family expressed in the developing nervous system in mice and Drosophila.
Mech. Dev. 99 (2000) 123–137.
[4] P. Kraus, G. Leong, V. Tan, X. Xing, J.W. Goh, S.P. Yap, T. Lufkin, A more cost effective
and rapid high percentage germ-line transmitting chimeric mouse generation pro-
cedure via microinjection of 2-cell, 4-cell, and 8-cell embryos with ES and iPS
cells. Genesis 48 (2010) 394–399, http://dx.doi.org/10.1002/dvg.20627.
[5] F.W. Farley, P. Soriano, L.S. Steffen, S.M. Dymecki, Widespread recombinase expres-
sion using FLPeR (ﬂipper) mice. Genesis 28 (2000) 106–110, http://dx.doi.org/10.
1002/1526-968X(200011/12)28:3/4.
[6] C.I. Rodriguez, F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, A.F. Stewart,
S.M. Dymecki, High-efﬁciency deleter mice show that FLPe is an alternative to Cre-
loxP. Nat. Genet. 25 (2000) 139–140, http://dx.doi.org/10.1038/75973.
[7] V. Sivakamasundari, H.Y. Chan, S.P. Yap, X. Xing, P. Kraus, T. Lufkin, New Bapx1Cre-
EGFP mouse lines for lineage tracing and conditional knockout studies. Genesis 50
(2012) 375–383, http://dx.doi.org/10.1002/dvg.20802.[8] X. Chen, X. Li, W. Wang, T. Lufkin, Dlx5 and Dlx6: an evolutionary conserved pair of
murine homeobox genes expressed in the embryonic skeleton. Ann. N. Y. Acad. Sci.
785 (1996) 38–47.
[9] P. Kraus, T. Lufkin, Mammalian Dlx homeobox gene control of craniofacial and inner
ear morphogenesis. J. Cell. Biochem. (Suppl 32-33) (1999) 133–140.
[10] D. Schmidt, M.D. Wilson, C. Spyrou, G.D. Brown, J. Hadﬁeld, D.T. Odom, ChIP-seq:
Using high-throughput sequencing to discover protein-DNA interactions. Methods
48 (2009) 240–248, http://dx.doi.org/10.1016/j.ymeth.2009.03.001.
[11] S. Chatterjee, V. Sivakamasundari, P. Kraus, S.P. Yap, V. Kumar, S. Prabhakar, T.
Lufkin, Gene expression proﬁles of Bapx1 expressing FACS sorted cells from
wildtype and Bapx1-EGFP null mouse embryos. Genom Data 5 (2015) 103–105,
http://dx.doi.org/10.1016/j.gdata.2015.05.031.
[12] Y. Zhang, T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, B.E. Bernstein, C. Nusbaum,
R.M. Myers, M. Brown, W. Li, X.S. Liu, Model-based analysis of ChIP-seq (MACS). Ge-
nome Biol. 9 (2008) R137, http://dx.doi.org/10.1186/gb-2008-9-9-r137.
[13] S. Mertin, S.G.McDowall, V.R. Harley, The DNA-binding speciﬁcity of SOX9 and other
SOX proteins. Nucleic Acids Res. 27 (1999) 1359–1364, http://dx.doi.org/10.1093/
nar/27.5.1359.
[14] D.W. Kim, H. Kempf, R.E. Chen, A.B. Lassar, Characterization of Nkx3.2 DNA binding
speciﬁcity and its requirement for somitic chondrogenesis. J. Biol. Chem. 278 (2003)
27532–27539, http://dx.doi.org/10.1074/jbc.M301461200.
[15] C.Y. McLean, D. Bristor, M. Hiller, S.L. Clarke, B.T. Schaar, C.B. Lowe, A.M. Wenger, G.
Bejerano, GREAT improves functional interpretation of cis-regulatory regions. Nat.
Biotechnol. 28 (2010) 495–501. 10.1038/nbt.1630.
